Cargando…

Activated Platelets, the Booster of Chronic Kidney Disease and Cardiovascular Complications

Background Chronic kidney disease (CKD) has become a global public health problem nowadays. As cardiovascular diseases (CVDs) are the primary cause of death in advanced CKD patients, much attention has been paid to resolving their cardiovascular complications. However, managing CKD and cardiovascula...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gong, Shuiqin, Wang, Chenyu, Xiong, Jiachuan, Zhao, Jinghong, Yang, Ke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386414/ https://www.ncbi.nlm.nih.gov/pubmed/36157264 http://dx.doi.org/10.1159/000525090

Ejemplares similares

A Nomogram for Identifying Subclinical Atherosclerosis in Chronic Kidney Disease
por: Xiong, Jiachuan, et al.
Publicado: (2021)

T-Lymphocyte Subsets Alteration, Infection and Renal Outcome in Advanced Chronic Kidney Disease
por: Xiong, Jiachuan, et al.
Publicado: (2021)

The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease
por: Huang, Yinghui, et al.
Publicado: (2022)

Controlling nutritional status score is associated with renal progression, cardiovascular events, and all-cause mortality in biopsy-proved diabetic kidney disease
por: Huo, Qingyu, et al.
Publicado: (2023)

Activation of EP4 alleviates AKI-to-CKD transition through inducing CPT2-mediated lipophagy in renal macrophages
por: Guan, Xu, et al.
Publicado: (2022)

The effectiveness of multidisciplinary care models for patients with chronic kidney disease: a systematic review and meta-analysis
por: Shi, Yu, et al.
Publicado: (2017)

REST contributes to AKI-to-CKD transition through inducing ferroptosis in renal tubular epithelial cells
por: Gong, Shuiqin, et al.
Publicado: (2023)

Targeting Myocardial Mitochondria-STING-Polyamine Axis Prevents Cardiac Hypertrophy in Chronic Kidney Disease
por: Han, Wenhao, et al.
Publicado: (2022)

Antiplatelet therapy for the prevention of atherosclerosis in chronic kidney disease (ALTAS-CKD) patients: study protocol for a randomized clinical trial
por: Xiong, Jiachuan, et al.
Publicado: (2021)

Oroxylin A ameliorates AKI-to-CKD transition through maintaining PPARα-BNIP3 signaling-mediated mitochondrial homeostasis
por: Yao, Mengying, et al.
Publicado: (2022)

Cardiovascular complications of pediatric chronic kidney disease
por: Mitsnefes, Mark M.
Publicado: (2008)

Cardiovascular Complications of Chronic Kidney Disease: An Introduction
por: Warrens, Hilary, et al.
Publicado: (2022)

Mitochondrial Damage‐Induced Innate Immune Activation in Vascular Smooth Muscle Cells Promotes Chronic Kidney Disease‐Associated Plaque Vulnerability
por: Bi, Xianjin, et al.
Publicado: (2021)

The RIFLE versus AKIN classification for incidence and mortality of acute kidney injury in critical ill patients: A meta-analysis
por: Xiong, Jiachuan, et al.
Publicado: (2015)

Potential Role of the Renal Arterial Resistance Index in the Differential Diagnosis of Diabetic Kidney Disease
por: Li, Haiyang, et al.
Publicado: (2022)

Association Between Body Mass Index Combined with Albumin: creatinine Ratio and All-cause Mortality in Chinese Population
por: Xiong, Jiachuan, et al.
Publicado: (2017)

Oxidative Stress and Cardiovascular Complications in Chronic Kidney Disease, the Impact of Anaemia
por: Nuhu, Faisal, et al.
Publicado: (2018)

Prevalence of chronic kidney disease in the Netherlands and its cardiovascular and renal complications
por: Vervloet, Marc G., et al.
Publicado: (2023)

Cardiovascular complications after COVID-19 in chronic kidney disease, dialysis and kidney transplant patients
por: Loutradis, Charalampos, et al.
Publicado: (2021)

Lack of Association between Interleukin-10 Gene Polymorphisms and Graft Rejection Risk in Kidney Transplantation Recipients: A Meta-Analysis
por: Xiong, Jiachuan, et al.
Publicado: (2015)

Urinary miR-196a predicts disease progression in patients with chronic kidney disease
por: Zhang, Changming, et al.
Publicado: (2018)

DUSP2-mediated inhibition of tubular epithelial cell pyroptosis confers nephroprotection in acute kidney injury
por: Xiong, Jiachuan, et al.
Publicado: (2022)

Platelets of patients with chronic kidney disease demonstrate deficient platelet reactivity in vitro
por: van Bladel, Esther R, et al.
Publicado: (2012)

Associations of platelet indices with proteinuria and chronic kidney disease
por: Kemeç, Zeki, et al.
Publicado: (2020)

438 Platelets, Inflammation and Thrombosis in Chronic Kidney Disease
por: Jain, Nishank, et al.
Publicado: (2023)

Neurological complications in chronic kidney disease
por: Arnold, Ria, et al.
Publicado: (2016)

A hypothesis-generating study to evaluate platelet activity in diabetics with chronic kidney disease
por: Brophy, Donald F, et al.
Publicado: (2005)

Correlation of increased Th17/Treg cell ratio with endoplasmic reticulum stress in chronic kidney disease
por: Zhu, Xiaojing, et al.
Publicado: (2018)

Cardiovascular disease in patients with chronic kidney disease
por: Wright, Julian, et al.
Publicado: (2009)

Cardiovascular Disease in Diabetes and Chronic Kidney Disease
por: Swamy, Sowmya, et al.
Publicado: (2023)

Computational Models Used to Predict Cardiovascular Complications in Chronic Kidney Disease Patients: A Systematic Review
por: Burlacu, Alexandru, et al.
Publicado: (2021)

Platelets, Aspirin and Cardiovascular Disease
por: Elwood, P. C.
Publicado: (1976)

10. Cardiovascular Risk in Chronic Kidney Disease
por: Lainščak, Mitja
Publicado: (2009)

Cardiovascular Calcification Heterogeneity in Chronic Kidney Disease
por: Hutcheson, Joshua D., et al.
Publicado: (2023)

Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association
por: Zoccali, Carmine, et al.
Publicado: (2023)

The link between chronic kidney disease and cardiovascular disease
por: Said, Sarmad, et al.
Publicado: (2014)

Chronic Kidney Disease and Cardiovascular Disease: Is there Any Relationship?
por: Vallianou, Natalia G., et al.
Publicado: (2019)

Role of asymptomatic hyperuricemia in the progression of chronic kidney disease and cardiovascular disease
por: Waheed, Yousuf, et al.
Publicado: (2021)

The role of roxadustat in chronic kidney disease patients complicated with anemia
por: Liu, Jie, et al.
Publicado: (2023)

Young-Adult Polycystic Kidney Disease is Associated with Major Cardiovascular Complications
por: Chuang, Ya-Wen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qttq5gqjumcn4nr3d9t73qn7f7